Participated · Equity · Jun 2026

Rylo develops an AI-powered communication platform that delivers real-time captioning for phone calls, in-person transcription, and text-to-speech responses to improve accessibility in personal and professional settings. The platform includes features such as sentiment analysis, speaker recognition, and fraud detection, and expanded its capabilities after acquiring Sign.mt in 2025 to launch Rylo Sign for real-time sign language translation. Rylo targets both individual and enterprise users and aims to reduce dependence on third-party interpreters while improving reliability and responsiveness in high-pressure environments. The company refines its AI models based on real user feedback and emphasizes privacy and regulatory compliance. Rylo plans to invest its new funding to grow engineering, product, and commercial teams, strengthen AI research, and scale infrastructure as it pursues global expansion and broader product offerings.

Participated · Series B · Mar 2026

Sigma360 offers an enterprise-grade platform that unifies global risk data, proprietary intelligence, screening technology, and AI automation to help financial institutions detect and prevent financial crime in real time. The solution supports point-in-time screening and perpetual client monitoring, reducing false positives and easing compliance burdens for banks, payment providers, fintechs, and other regulated corporations. Over the past two years the company achieved 5× revenue growth, reached profitability in 2025, and posts 140%+ Net Revenue Retention with 95% Gross Revenue Retention. Its technology now safeguards more than $2 trillion in assets and processes billions of dollars in transaction value each month. Recognitions include being named Chartis Research’s #1 adverse media screening platform in both 2025 and 2026 and a KYC quadrant leader in 2025. Future plans for the newly raised funds center on enriching proprietary risk datasets, deepening AI automation, and expanding global go-to-market efforts across regulated financial sectors. The company is headquartered in New York and was founded by former U.S. Treasury and National Counterterrorism Center official Stuart Jones, Jr.

Participated · Seed · Feb 2026

EFEX offers a treasury and cross-border payments platform that lets mid-market businesses open multi-currency accounts, collect funds in local currency across 31 countries, and send transfers to more than 140 destinations. The service consolidates individual, bulk, and forward transfers under a single interface regulated by Mexico’s CNBV. In 2025 the company processed over US$1 billion in payment volume and achieved a six-fold increase in revenue, demonstrating strong traction ahead of its latest raise. Founded by Dimitri Zaninovich and Santiago Bustamante, EFEX maintains headquarters in both Mexico and the United States. The firm plans to channel new capital into integrating artificial intelligence across its operational infrastructure and accelerating growth along the high-volume Mexico-U.S. trade corridor. Near-term, EFEX aims to become Mexico’s default corporate treasury platform, while longer-term it intends to remove friction for internationally expanding firms in sectors such as automotive, manufacturing, and food and beverage.

Participated · Series A · Jan 2026

Salvo Health offers brick-and-mortar gastrointestinal (GI) clinics a continuous virtual care platform that connects patients with a specialized, gut-focused care team. Users gain direct, ongoing access to registered dietitians, behavioral-health professionals, and nurses, helping clinics save time, boost revenue, and improve outcomes. In 2025 the company reported 800% year-over-year growth in both patients and revenue and expanded enterprise agreements with GI doctors by more than 1,000%, reaching 801 signed GI partners. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, the company is now building an AI-driven product roadmap. The new funding will finance engineering expansion and nationwide hiring of additional clinical staff to meet rising demand. Salvo Health positions itself at the intersection of virtual specialty care and chronic condition management, with ambitions to scale its platform nationally.

Participated · Series A · Nov 2025

Founded in 2020 and headquartered in Boston, OnRamp offers an intelligent platform that automates onboarding workflows, surfaces insights, and streamlines customer engagement for enterprise customer-success teams. Its product suite now includes AI Summaries, which analyze reports to deliver written insights, recommendations, and visualizations, and it plans to roll out additional AI-driven onboarding functionality through 2025 and 2026. The company reports serving hundreds of customers, including three of the Fortune 15, and helping them cut onboarding time by 60 % and, in some cases, achieve nearly 100 % completion rates. OnRamp claims more than 100 % year-over-year revenue growth, fueled by demand to decrease churn, speed time-to-value, and accelerate revenue realization. Recent customer testimonials cite doubled onboarding capacity and halved go-live timelines within three months of adoption. With its latest financing, the company will expand product and engineering teams, enhance AI capabilities, and open a 6,000-square-foot Boston office in early 2026. Total capital raised now stands at $27 million, positioning OnRamp to deepen its market presence and continue scaling upmarket.